Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhat to expect week by week on oral semaglutide, and why the timeline looks the way it does
The myth: you'll drop weight within days of your first tablet
Here's the belief that trips people up most. Because online chatter frames these medicines as fast, many people expect the scales to fall in the first week. That's not how oral semaglutide behaves, and expecting it to sets you up for disappointment by day five.
What actually happens early on is subtler. Semaglutide is a GLP-1 receptor agonist that slows how quickly your stomach empties and turns up your sense of fullness. Plenty of people notice they're satisfied sooner at meals, or that snacking loses its pull, within the first week or two. That appetite change is real and it's the medicine working. It just isn't the same thing as weight loss showing on the scales.
The reason is the dosing schedule. Wegovy tablets start low, at 1.5mg once daily, and step up through 4mg and 9mg to a 25mg maintenance dose, with a minimum of a month at each level. Those first weeks exist to let your system settle, not to treat your weight. So the early phase is deliberately gentle, which is exactly why the scales stay quiet.
If you want the fuller picture of the numbers involved, our page on what results people saw with semaglutide tablets walks through the trial figures in plain terms. The short version: patience is built into the design. The tablet's job in month one is adjustment, not transformation.
The first two weeks: what you'll notice, and what you won't
Think of the opening fortnight as the settling-in period. On the 1.5mg starting dose, the most common early experiences are appetite-related and digestive rather than dramatic. Many people describe smaller portions feeling like enough, or losing interest in food they'd normally reach for. That's the medicine acting on your gut hormones and gastric emptying.
Alongside that, some early side effects are common as your body adjusts. Gastrointestinal effects lead the list: nausea, mild queasiness, changes in bowel habit, indigestion or burping. In the oral semaglutide trial, gut-related side effects were the most frequently reported, generally mild to moderate and tending to ease over time rather than persist. They're usually most noticeable soon after starting or after a dose increase, then settle within days to a couple of weeks.
What you probably won't see in this window is a big change on the scales, and that's entirely normal. A pound or two of early movement can reflect appetite reduction and shifting fluid rather than steady fat loss. The real trajectory takes longer to establish.
How you take the tablet matters for it to work properly. Oral semaglutide is taken first thing in the morning on an empty stomach with a small sip of plain water, then you wait at least 30 minutes before any food, drink or other medicines. That half-hour gap protects absorption. Get into a rhythm with it early, because consistency in these first weeks sets up everything that follows. The NHS guidance on semaglutide and how it's used is a sound reference while you find your footing.
Months one to three: the dose climbs, and momentum starts
This is where the timeline earns its shape. Because each dose level sits for at least a month before stepping up, you spend the first quarter of treatment moving through the lower rungs of the schedule. By the end of month three you'll typically still be building towards, or newly arrived at, a higher maintenance dose. Weight loss tends to become steadier and more visible as the dose increases and your appetite response deepens.
It helps to reframe what "working" means here. The appetite effect you felt in week one doesn't max out immediately; it strengthens as the dose does. So the middle stretch is often when people start seeing a consistent downward trend on the scales rather than isolated dips. Progress across this phase is usually measured in a gradual weekly or fortnightly change, not sudden drops.
Each step up can bring a short return of the early digestive effects, which usually calm again within a week or so as your body adapts to the new level. That's expected, and it's part of why the schedule is paced the way it is. Rushing the increases tends to worsen side effects without speeding results, which is why titration is a clinical decision, not a self-adjustment.
One practical note on timing your life around this: because progress is gradual, there's no benefit to timing your start around a payday or a holiday for a quick pre-event result. It doesn't work that way. Steady daily use across months is what delivers, so the best start date is simply the one you can be consistent with. If you'd like to understand how the medicine clears from your body between doses, we've explained how long oral semaglutide stays in your system separately.
The full trial timeline: what 64 weeks actually showed
The clearest guide to how long these tablets take to work comes from the trial behind the UK approval. In the OASIS 4 study, 307 adults with obesity, or with excess weight plus a weight-related condition and without diabetes, took oral semaglutide alongside lifestyle changes for 64 weeks. On average, participants lost around 13.6% of their body weight over that period, compared with roughly 2.4% on placebo. Among those who stayed fully adherent to treatment throughout the trial, average loss reached about 17%.
The word to hold onto is "over". That 13.6% average was not a fast result; it accrued across 64 weeks as the dose climbed and the effect compounded. Weight loss on GLP-1 medicines characteristically builds through the first year and then tends towards a plateau, which is why the trials ran as long as they did. If your yardstick is a month, you're measuring the wrong window.
These figures also carry the usual honest caveats. Trial averages are exactly that, averages. Individual results vary widely around the mean, and results were achieved alongside a reduced-calorie diet and increased activity, not instead of them. The tablet supports the effort; it doesn't replace it. The full study detail sits with the MHRA's approval materials and the manufacturer's summary, and you can read the plain-English breakdown on our semaglutide tablets results page.
For the broader context of GLP-1 evidence and how NHS bodies assess it, the NICE appraisal of semaglutide is a useful anchor, even though it covers the injection rather than the tablet. It gives a sense of the evidence bar these medicines are held to.
What makes the tablet work faster or slower for you
The headline timeline is a rough map, not a promise, because several things pull an individual's pace either way. Adherence is the biggest lever. The OASIS 4 data made this stark: those who stuck fully to treatment averaged around 17%, well above the 13.6% figure for the whole group. Missing tablets, or taking them incorrectly, blunts the effect.
How you take it matters as much as whether you take it. Because oral semaglutide is absorbed in a narrow window, the empty-stomach rule and the 30-minute wait aren't optional niceties. Taking the tablet with food, too little water, or too close to other medicines can reduce how much gets absorbed, which slows things down. Getting the routine right is one of the most controllable factors in your own timeline.
Then there's the rest of your life. Diet quality, protein intake, activity levels, sleep and stress all shape how the scales respond. Semaglutide reduces appetite, but what you eat within that reduced appetite still counts, which is why protein adequacy and some strength activity matter as weight comes off. The NHS healthy weight advice is a sensible companion to treatment.
Biology plays its part too. Starting weight, metabolism and individual response to GLP-1 signalling all vary, which is why two people on the same dose can lose weight at different rates. There's no single "normal" pace. If you want to explore how the tablets fit alongside other options, our overview of weight-loss treatment approaches sets out the landscape without the hype.
How long until you know if it's working at all?
There's a fair question underneath all this: at what point should you conclude the tablets are, or aren't, doing the job for you? The clinical convention gives a useful benchmark. For GLP-1 weight-management medicines, response is typically assessed after around six months at the appropriate dose, with a review of whether to continue if weight loss falls short of about 5% by then. That's the yardstick NICE uses for semaglutide, and it reflects how gradual the effect is.
So the practical answer is that you'll have early signals within weeks, an emerging trend within a couple of months, and a fair read on whether it's genuinely working by around the half-year mark once you're established on a maintenance dose. Judging it any sooner risks abandoning something that simply hadn't reached its stride.
This is also where clinical review earns its keep. Progress isn't just about the number on the scales; a prescriber looks at how you're tolerating the medicine, whether the dose is right, and what's happening with any weight-related conditions. That whole-picture view is why these tablets are prescription-only and reviewed by a clinician rather than judged by the reader alone.
It's worth being clear on a distinction people miss: Wegovy tablets are semaglutide licensed for weight management. Rybelsus is also oral semaglutide, but it's licensed for type 2 diabetes at different strengths, not for weight loss. If a search led you to diabetes-strength tablets, that's a separate product with a separate purpose. Our page on how the weight-management tablet works keeps that distinction clear.
Getting started safely, if the timeline suits you
If a slow, steady, once-daily route appeals more than a weekly injection, oral semaglutide may be worth exploring, and understanding the realistic timeline is half the battle already won. The route to it in the UK is straightforward but properly regulated: these are prescription-only medicines, so treatment follows a clinical assessment rather than an off-the-shelf purchase.
At nume, the process is built around a real clinician reading your answers, not a piece of software waving them through. You complete a free consultation, a GPhC-registered Independent Prescriber reviews it the same day, and if treatment is clinically suitable, your order is dispatched with everything included in one transparent price: consultation, prescription, delivery and aftercare seven days a week. There are no subscriptions and every repeat order is clinically re-reviewed. You can read about our clinical team and who we are if you'd like to know who stands behind that.
A word on cost, since it shapes many decisions: private weight-loss treatment is priced per month and varies by provider and dose, and any legitimate price should include the prescription and clinical assessment, not just the medicine. We're not the cheapest listing you'll find, and that's a deliberate choice about what the price buys you. The specifics for the tablets sit on our Wegovy tablets cost page.
If you'd rather ask a question before deciding, our support team is reachable seven days a week. Start your free consultation when you're ready, and let a prescriber tell you whether the tablets fit your situation.
Related questions we've answered
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.